Relationship between dyslipidemia C-Reactive Protein and serological evidence of chlamydia pneumoniae in Turkish patients with coronary artery diseases

Loading...
Publication Logo

Date

2004

Authors

Türkoğlu, Celalettin
Sönmez, Emine
Aydınlı, Aydın

Journal Title

Journal ISSN

Volume Title

Publisher

Luigi Ponzio E Figlio

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Average

Research Projects

Journal Issue

Abstract

Relationship between dyslipidemia C-Reactive Protein (CRP) and serological evidence of Chlamydia pneumoniae was investigated in a Turkish population with coronary artery disease. This prospective randomized blinded study was carried out in Florence Nightingale Hospital which is affiliated to Kadir Has University Medical Faculty. Thirty-two patients with acute coronary artery diseases (ACAD) 32 patients with chronic coronary artery diseases (CCAD) and 26 healthy controls (HC) were included in the study We detected serum concentrations of C. pneumoniae IgG IgA and IgM by ELISA method. We measured total cholesterol trigliseride LDL and HDL- cholesterol levels to determine dyslipidemia which was defined as total cholesterol >200 mg/dL trigliserid > 150 Mg/dL LDL >130 mg/dL HDL <45 mg/dL. CRP levels were also measured. Seropositivity to C. pneumoniae IgG was 84.3% 100% and 65.3%
seropositivity to IgA was 9.3% 6.2% and 3.8%
and seropositivity to IgM was 12.5% 15.3% and 15.4% in patients with ACAD CCAD and HC respectively. Dyslipidemia was found as 93.7% 78.1% and 0% of patients with ACAD CCAD and HC respectively. CRP level was high in all patients (ACAD CCAD) but not in healthy controls. As a conclusion we found a significant association between seropositivity to C. pneumoniae IgG and dyslipidemia and CRP levels in ACAD and CCAD patients (p<0.05). C. pneumoniae IgG antibodies should he evaluated together with serum lipids and CRP levels in patients with ACAD and CCAD in Turkish population. This may help clinicians in treatment of C. pneumoniae infection and decrease the risk of coronary artery diseases.

Description

Keywords

C pneumoniae, Coronary artery disease, Dyslipidemia, CRP, Male, Turkey, cholesterol blood level, serology, Coronary Artery Disease, immunoglobulin A, lipid blood level, Coronary artery disease, immunoglobulin G, immunoglobulin M, Prospective Studies, Chlamydia, Chlamydophila Infections, risk, clinical article, C reactive protein, C pneumoniae, adult, article, Chlamydophila pneumoniae, Middle Aged, Coronary Arteriosclerosis, Antibodies, Bacterial, Lipoproteins, LDL, aged, female, C-Reactive Protein, Cholesterol, high density lipoprotein, Female, triacylglycerol, CRP, Lipoproteins, HDL, Adult, Enzyme-Linked Immunosorbent Assay, Hyperlipidemias, male, Humans, controlled study, human, C. Pneumoniae, Triglycerides, Aged, Chlamydophila, disease association, dyslipidemia, ischemic heart disease, Randomized Controlled Trials, enzyme linked immunosorbent assay, Immunoglobulin A, Dyslipidemia, Immunoglobulin M, Immunoglobulin G, measurement, low density lipoprotein, population research

Fields of Science

0302 clinical medicine, 03 medical and health sciences

Citation

WoS Q

Q4

Scopus Q

Q3
OpenCitations Logo
OpenCitations Citation Count
N/A

Source

The new microbiologica

Volume

27

Issue

3

Start Page

229

End Page

234
PlumX Metrics
Citations

Scopus : 3

PubMed : 1

Captures

Mendeley Readers : 16

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
0.4252

Sustainable Development Goals